BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8105615)

  • 1. Longitudinal study of excretion of metabolites of polycyclic aromatic hydrocarbons in urine from two psoriatic patients.
    Hansen AM; Poulsen OM; Menné T
    Acta Derm Venereol; 1993 Jun; 73(3):188-90. PubMed ID: 8105615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological monitoring of human exposure to coal tar. Urinary mutagenicity assays and analytical determination of polycyclic aromatic hydrocarbon metabolites in urine.
    Clonfero E; Jongeneelen F; Zordan M; Levis AG
    IARC Sci Publ; 1990; (104):215-22. PubMed ID: 2228119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological monitoring of human exposure to coal tar. Urinary excretion of total polycyclic aromatic hydrocarbons, 1-hydroxypyrene and mutagens in psoriatic patients.
    Clonfero E; Zordan M; Venier P; Paleologo M; Levis AG; Cottica D; Pozzoli L; Jongeneelen FJ; Bos RP; Anzion RB
    Int Arch Occup Environ Health; 1989; 61(6):363-8. PubMed ID: 2744865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers.
    Santella RM; Nunes MG; Blaskovic R; Perera FP; Tang D; Beachman A; Lin JH; DeLeo VA
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):137-40. PubMed ID: 8049634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary 1-naphthol and 1-pyrenol as indicators of exposure to coal tar products.
    Heikkilä P; Luotamo M; Pyy L; Riihimäki V
    Int Arch Occup Environ Health; 1995; 67(3):211-7. PubMed ID: 7591181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of humans exposed to therapeutical coal tar.
    Clonfero E; Zordan M; Cottica D; Venier P; Pozzoli L; Cardin EL; Sarto F; Levis AG
    Carcinogenesis; 1986 May; 7(5):819-23. PubMed ID: 3698208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of different bacterial assays in detecting mutagens in urine of humans exposed to polycyclic aromatic hydrocarbons.
    Granella M; Clonfero E
    Mutat Res; 1992 Jul; 268(1):131-7. PubMed ID: 1378179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar.
    Roelofzen JH; van der Valk PG; Godschalk R; Dettbarn G; Seidel A; Golsteijn L; Anzion R; Aben KK; van Schooten FJ; Kiemeney LA; Scheepers PT
    Toxicol Lett; 2012 Aug; 213(1):39-44. PubMed ID: 21810456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal alterations in peripheral blood lymphocytes, urinary mutagenicity and excretion of polycyclic aromatic hydrocarbons in six psoriatic patients undergoing coal tar therapy.
    Sarto F; Zordan M; Tomanin R; Mazzotti D; Canova A; Cardin EL; Bezze G; Levis AG
    Carcinogenesis; 1989 Feb; 10(2):329-34. PubMed ID: 2643486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological monitoring of polycyclic aromatic hydrocarbons. Metabolites in urine.
    Jongeneelen FJ; Bos RP; Anzion RB; Theuws JL; Henderson PT
    Scand J Work Environ Health; 1986 Apr; 12(2):137-43. PubMed ID: 3726495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between polycyclic aromatic hydrocarbons in air and in urine of workers in a Söderberg potroom.
    Tjoe Ny E; Heederik D; Kromhout H; Jongeneelen F
    Am Ind Hyg Assoc J; 1993 Jun; 54(6):277-84. PubMed ID: 8328359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airborne concentrations, skin contamination, and urinary metabolite excretion of polycyclic aromatic hydrocarbons among paving workers exposed to coal tar derived road tars.
    Jongeneelen FJ; Scheepers PT; Groenendijk A; Van Aerts LA; Anzion RB; Bos RP; Veenstra SJ
    Am Ind Hyg Assoc J; 1988 Dec; 49(12):600-7. PubMed ID: 3213813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uptake of pyrene in a breast-fed child of a mother treated with coal tar.
    Scheepers PT; van Houtum JL; Anzion RB; Harder R; Bos RP; van der Valk PG
    Pediatr Dermatol; 2009; 26(2):184-7. PubMed ID: 19419468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The urinary mutagenicity test in monitoring exposure to aromatic polycyclic hydrocarbons in workers in the aluminum industry].
    Granella M; Venier P; Zordan M; Clonfero E
    Med Lav; 1992; 83(5):511-8. PubMed ID: 1297066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product.
    Jongeneelen FJ; Anzion RB; Leijdekkers CM; Bos RP; Henderson PT
    Int Arch Occup Environ Health; 1985; 57(1):47-55. PubMed ID: 4077281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of workers exposed to coal tar pitch volatiles in an anode plant.
    Venier P; Clonfero E; Cottica D; Gava C; Zordan M; Pozzoli L; Levis AG
    Carcinogenesis; 1985 May; 6(5):749-52. PubMed ID: 4006058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Longitudinal study of the excretion of 1-hydroxypyrene in urine after external treatment with coal tar].
    Nenoff P; Richter B; Will W; Haustein UF
    Hautarzt; 1997 Apr; 48(4):240-5. PubMed ID: 9206711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly increased urinary 1-hydroxypyrene excretion rate in patients with atopic dermatitis treated with topical coal tar.
    Veenhuis RT; van Horssen J; Bos RP; Anzion RB; Van Der Valk PG
    Arch Dermatol Res; 2002 Jul; 294(4):168-71. PubMed ID: 12111346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A guidance value of 1-hydroxypyrene in urine in view of acceptable occupational exposure to polycyclic aromatic hydrocarbons.
    Jongeneelen FJ
    Toxicol Lett; 2014 Dec; 231(2):239-48. PubMed ID: 24831967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatological exposure to coal tar and bladder cancer risk: a case-control study.
    Roelofzen JHJ; Aben KKH; Van de Kerkhof PCM; Van der Valk PGM; Kiemeney LALM
    Urol Oncol; 2015 Jan; 33(1):20.e19-20.e22. PubMed ID: 24629496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.